Dr. Athiya Agarwal reported the acquisition of 21,15,180 shares (0.67%) in Dr. Agarwal’s Health Care Limited from Dr. Anosh Agarwal on March 4, 2026. The transfer was executed as a ‘Gift’ via an inter-se transfer between immediate relatives within the Promoter Group. This transaction, being exempt, resulted in no change to the total combined shareholding of the Promoter and Promoter Group.
Acquisition via Inter-Se Transfer by Promoter Relative
This disclosure details a transaction involving the Promoter Group of Dr. Agarwal’s Health Care Limited (the Target Company, TC). Dr. Athiya Agarwal is reporting the acquisition of 21,15,180 equity shares, equivalent to 0.67% of the TC’s total share capital, as of the transaction date, March 4, 2026.
The acquisition occurred through an inter-se transfer of shares amongst individuals belonging to the Promoter Group. Specifically, the shares were transferred by Dr. Anosh Agarwal to Dr. Athiya Agarwal. The relationship between the transferor (seller) and the acquirer is defined as Immediate Relative.
Transaction Details and Exemption Rationale
The transaction was executed by way of ‘Gift’, meaning no consideration was involved in the transfer price. This type of transaction falls under an exemption provided under the regulations, specifically relating to inter-se transfers among immediate relatives within the Promoter Group.
Prior Intimation for this proposed acquisition was filed with the stock exchanges on February 24, 2026, satisfying the necessary timeline requirements.
Shareholding Summary Post-Transaction
Despite the transfer, the overall holding percentage of the consolidated Promoter and Promoter Group remains unchanged. The detailed shareholding breakdown shows the following shifts for the involved parties:
Acquirer (Dr. Athiya Agarwal)
- Pre-Transaction Holding: 1,05,46,795 shares, representing 3.33% of total capital.
- Post-Transaction Holding: 1,26,61,975 shares, increasing her stake to 4.00% of total capital.
Seller (Dr. Anosh Agarwal)
- Pre-Transaction Holding: 1,69,73,100 shares, representing 5.36% of total capital.
- Post-Transaction Holding: 1,48,57,920 shares, decreasing his stake to 4.69% of total capital.
The filings confirm that the net effect on the combined Promoter Group holding is zero, as the 21,15,180 shares moved internally from one member to another within the immediate relative classification.
Source: BSE
